Liver Diseases: all 2,094 studies
Page 12 of 21. Open to participants first (390), then studies with results posted, then the rest; newest registration first within each.
- Egyptian Liver Library: Rebuilding the Pyramid of Liver Disease Evidence in EgyptCompletedNCT04465747
- The Effect of Consecutive Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT04465032Phase 4
- Organ Dysfunction Associated With Intra Abdominal Pressures in Liver TransplantationStatus unknownNCT04463745
- Impact of Exercise Intervention for Patients With Non-alcoholic Fatty Liver DiseaseActive, not recruitingNCT04463667Not applicable
- Mean Systemic Filling Pressure Trends in Liver Transplant RecipientsCompletedNCT04462874
- Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes PatientsCompletedNCT04462081
- Effect of Midodrine on HVPG in Advanced Chronic Liver DiseaseCompletedNCT04455464Not applicable
- Nonalcoholic Fatty Liver Disease (NAFLD) Database 3CompletedNCT04454463
- Efficacy of Nutritional Therapy With High Methionine Content in the Treatment of NAFLDCompletedNCT04450875Not applicable
- Liver Diseases in PLWHStatus unknownNCT04446156
- Prevention and Reversion of NAFLD in Obese Patients With Metabolic Syndrome by Mediterranean Diet and Physical ActivityStatus unknownNCT04442620Not applicable
- Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based StudyTerminatedNCT04440540Not applicable
- COVID-19 in Patients With Chronic Liver DiseasesCompletedNCT04439084
- Avatrombopag for Thrombocytopenia in People With CancerWithdrawnNCT04437953Phase 2
- The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy SubjectsCompletedNCT04422496Phase 1
- COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational StudyStatus unknownNCT04422379
- Prospective Cohort Study of Disease and Outcomes in CirrhosisStatus unknownNCT04422223
- The Precise Selection of Stent Diameter for Portal Hypertension Patients With TIPSStatus unknownNCT04421118
- Impact of the Covid-19 Pandemic on Gastrointestinal and Liver DiseasesCompletedNCT04420637
- Efficacy of Phosphatidylcholine in NAFLDCompletedNCT04411862Phase 3
- The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor.CompletedNCT04408937Phase 1
- Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19CompletedNCT04407182Phase 2
- Mediterranean Diet Versus Paleolithic Diet for the Treatment of Non Alcohlic Fatty Liver DiseaseStatus unknownNCT04400864Not applicable
- Effects of ACC Inhibitor on Lipid and Lipoprotein MetabolismWithdrawnNCT04395950Phase 1
- Combination Diagnostic Strategies in NAFLDCompletedNCT04384159
- The Use of the Transient Elastography Paediatric Probe, Compared to the M Probe, Indirect Biomarkers and HistologyCompletedNCT04380493
- COVID19-FOIE National ObservatoryCompletedNCT04375670
- A Prospective, Randomized, Placebo-Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Administration of Lyophilized PRIM-DJ2727 or Placebo Given Orally in Subjects With Nonalcoholic Fatty Liver DiseaseWithdrawnNCT04371653Phase 2
- Fatty Liver Among Employees at Banha UniversityCompletedNCT04367012
- Sulforaphane Supplementation StudyStatus unknownNCT04364360Not applicable
- Intermittent Fasting in Nonalcoholic Fatty Liver DiseaseStatus unknownNCT04355910Not applicable
- An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver DiseaseCompletedNCT04352491
- Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide)CompletedNCT04349696Phase 4
- Characterization and Technical Evaluation of cT1 for NASH (CATE-NASH)CompletedNCT04341246
- Gut Microbiota Metagenomics for Chronic Liver DiseaseStatus unknownNCT04339725
- Multi-Parametric MRI Assessment of the Liver in Diabetic Volunteers (Partners Registry)CompletedNCT04336800
- Multi-Parametric MRI Assessment of the Liver in the Dallas-FortWorth Metroplex PopulationCompletedNCT04336618
- A Study of JNJ-53718678 in Participants With Hepatic ImpairmentTerminatedNCT04332523Phase 1
- Metabolic Cofactor Supplementation in Obese Patients with Non-Alcoholic Fatty Liver DiseaseCompletedNCT04330326Phase 2
- Prevalance of non_ Alcoholic Fatty Liver Diseases in Patient With Inflammatory Bowel Diseases Attending Assiut University HospitalsStatus unknownNCT04328259
- The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin ResistanceTerminatedNCT04315350Not applicable
- CHESS Criteria for Varices Screening in Compensated Advanced Chronic Liver Disease (CHESS2001/APPHA2001)CompletedNCT04307264
- Pharmacokinetics, Pharmacodynamics and Safety of SHR4640 in Patients With Hepatic ImpairmentStatus unknownNCT04305392Phase 1
- Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic ImpairmentCompletedNCT04293029Phase 1
- Screening of NASH in Oupatients Followed in Various Hospital Specialty Clinics at the University Hospital of StrasbourgStatus unknownNCT04282447
- Metabolic Surgery for Steato-HepatitisStatus unknownNCT04282005Not applicable
- The Use of Novel Diagnostic Tools to Increase Detection of Early Fibrosis in Cystic Fibrosis Related Liver Disease to Improve Clinical ManagementCompletedNCT04277819
- Study of Single-dose DS-3201b in Participants With Hepatic ImpairmentCompletedNCT04276662Phase 1
- Kidney Affection in Non Alcaholic Fatty Liver DiseasesCompletedNCT04273230
- EXerCise Intervention in cholesTatic LivEr Disease: The EXCITED StudyTerminatedNCT04265235Not applicable
- Mindfulness and Shared Decision MakingCompletedNCT04255082
- The Effect of Hepatic Impairment on Aprocitentan PharmacokineticsCompletedNCT04252495Phase 1
- Effect of BCAA Supplementation on Muscle Mass, Muscle Quality and Molecular Markers of Muscle Regeneration in CLD PatientsCompletedNCT04246918Not applicable
- Combined Effect of Acitretin and Narrow Band Ultraviolet B on Vitiligo RepigmentationStatus unknownNCT04245319Not applicable
- Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver DiseaseCompletedNCT04235205Phase 2
- Weight Loss in Adults With Obesity Using a Combination of Low Energy Diet, Group Treatment and Intragastric BalloonStatus unknownNCT04230655Not applicable
- MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH)Active, not recruitingNCT04227782
- A Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986263 in Participants With Varying Degrees of Liver ImpairmentCompletedNCT04225936Phase 1
- Evaluation of Frailty and Functional Capacity in End-Stage Liver DiseaseCompletedNCT04220723
- T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver DiseaseStatus unknownNCT04220450
- Screening and Identifying Hepatobiliary Diseases Via Deep Learning Using Ocular ImagesCompletedNCT04213183
- A Study to Evaluate the Effect of Hepatic Impairment on JNJ-56136379CompletedNCT04208399Phase 1
- A Study to Evaluate the Effect of Hepatic Impairment on JNJ-73763989CompletedNCT04208386Phase 1
- A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease PatientsCompletedNCT04197479Phase 3
- An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH)Status unknownNCT04193982Phase 3
- Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)Status unknownNCT04191044
- GastrOesophageal Varices After Sustained Virological ResponseStatus unknownNCT04191018
- Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major MetaboliteCompletedNCT04190654Phase 1
- Comparison of Dietary Sugar Reduction MethodsCompletedNCT04186793Not applicable
- Estimation of Minimum Efficacy Daily Dose of Jarlsberg CheeseCompletedNCT04185454Not applicable
- Ischemic Preconditioning at a Distance in Liver SurgeryCompletedNCT04181502Not applicable
- KD025 Hepatic Impairment Study With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic ImpairmentCompletedNCT04166942Phase 1
- Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORERCompletedNCT04165343
- Effect of Focused Ultrasound on Abdominal and Intrahepatic Fat in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT04161703Not applicable
- APHP Plateform of Normothermic Perfusion for Rehabilitation of Hepatic GraftsStatus unknownNCT04154696Not applicable
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy SubjectsCompletedNCT04146805Phase 1
- Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Hepatic ImpairmentCompletedNCT04145596Phase 1
- Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver CirrhosisCompletedNCT04142749Phase 3
- Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in HumansCompletedNCT04130321Not applicable
- The Role of Bariatric Surgeries in Management of Nonalcoholic Fatty Liver DiseaseStatus unknownNCT04127370Not applicable
- Metagenomic Next-Generation Sequencing for Diagnosis of Ascites Infection in End-stage Liver DiseasesStatus unknownNCT04125654Not applicable
- Study on PK of Hydronidone in Patients and Special PopulationCompletedNCT04123769Phase 1
- Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic SyndromeCompletedNCT04117802Not applicable
- MERTK Signalling in Monocytes/Macrophages in Patients With Liver DiseaseCompletedNCT04116242
- Curcumin for Pediatric Nonalcoholic Fatty Liver DiseaseWithdrawnNCT04109742Phase 2
- Somatostatin in Living Donor Liver TransplantationStatus unknownNCT04107428Phase 4
- Invasive Fungal Infections in Severe Alcohol-associated HepatitisStatus unknownNCT04103840
- NAFLD Study: US vs Liver BiopsyStatus unknownNCT04101162Not applicable
- Preoperative Evaluation of the Remaining Part of the Liver for Liver ResectionStatus unknownNCT04100304Not applicable
- Pirfenidone and Advanced Liver Fibrosis.CompletedNCT04099407Phase 2
- Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.Status unknownNCT04099147
- Biological Adaptations of Strength Training.CompletedNCT04098484Not applicable
- Bleeding in Hospitalized Patients With Liver Disease Undergoing Invasive ProceduresCompletedNCT04076605
- The Effect of Probiotics on the Clinical Outcomes and Gut Microenvironment in Patients With Fatty LiverStatus unknownNCT04074889Not applicable
- Early Detection of Alcoholic Liver DiseaseWithdrawnNCT04070508
- Physical Recovery After Laparoscopic vs. Open Liver ResectionCompletedNCT04067349Not applicable
- Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation InterventionsCompletedNCT04066153
- Macrophage-mediated Inflammation in White Adipose Tissue and Non-alcoholic Fatty Liver Disease.CompletedNCT04059068
- Nonalcoholic Fatty Liver Disease in Morbidly Obese PatientsStatus unknownNCT04059029
- A Study of MHE in Patients With Liver DiseasesCompletedNCT04058327